Wordt geladen...
DEMETHYLATING AGENTS IN MYELOID MALIGNANCIES
PURPOSE OF REVIEW: Two demethylating agents are approved in myelodysplastic syndromes (MDS): 5-azacitidine and 5-aza-2′-deoxycitidine (decitabine). These drugs are structurally related and induce DNA hypomethylation. Aberrant DNA methylation is associated with gene silencing. It is proposed that hyp...
Bewaard in:
| Hoofdauteur: | |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2008
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3873866/ https://ncbi.nlm.nih.gov/pubmed/18841054 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CCO.0b013e328313699c |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|